Zilver PTX Post-Market Study in Japan
Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan
Sponsor: Cook Group Incorporated
A NA clinical study on Peripheral Arterial Disease (PAD), this trial is completed. The trial is conducted by Cook Group Incorporated and has accumulated 9 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2019 — Jan 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Aug 2018 — Aug 2019 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
May 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cook Group Incorporated
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.